1. Bufalin reverses multidrug resistance by regulating stemness through the CD133/nuclear factor‐κB/MDR1 pathway in colorectal cancer
   Yueping Zhan et al, 2020, Cancer Science CrossRef
2. Advances in the treatment of pancreatic cancer with traditional Chinese medicine
   Yanhua Zhang et al, 2023, Frontiers in Pharmacology CrossRef
3. Bufalin Induces Apoptosis and Improves the Sensitivity of Human Glioma Stem-Like Cells to Temozolamide
   Jia Liu et al, 2019, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
4. Molecular mechanisms of bufadienolides and their novel strategies for cancer treatment
   Li-Juan Deng et al, 2020, European Journal of Pharmacology CrossRef
5. Super Para-Magnetic Iron Oxide Nanoparticles (SPIONs) in the Treatment of Cancer: Challenges, Approaches, and its Pivotal Role in Pancreatic, Colon, and Prostate Cancer
   Sameea Ahmed Khan et al, 2023, Current Drug Delivery CrossRef
6. Bufalin serves as a pharmaceutic that mitigates drug resistance
   Linxuan Miao et al, 2023, Drug Metabolism Reviews CrossRef
7. Molecular mechanisms underlying the�antimetastatic activity of bufalin (Review)
   Jie Wang et al, 2018, Molecular and Clinical Oncology CrossRef
8. Bufalin Suppresses Colorectal Cancer Cells by the Blockade of Canonical Wnt Signaling Pathway
   Wanmi Sui et al, 2022, 2022 4th International Conference on Intelligent Medicine and Image Processing CrossRef
9. Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer
   Sheema Khan et al, 2019, Biomaterials CrossRef
10. New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin
    Chien-shan Cheng et al, 2019, Cancer Cell International CrossRef
11. The inhibition of heme oxygenase-1 enhances the chemosensitivity and suppresses the proliferation of pancreatic cancer cells through the SHH signaling pathway
    Liang Han et al, 2018, International Journal of Oncology CrossRef
12. Induction of Apoptosis in Human Pancreatic Cancer Stem Cells by the Endoplasmic Reticulum-Targeted Alkylphospholipid Analog Edelfosine and Potentiation by Autophagy Inhibition
    Consuelo Gajate et al, 2021, Cancers CrossRef
13. Bufalin for an innovative therapeutic approach against cancer
    Laura Soumoy et al, 2022, Pharmacological Research CrossRef
14. Reactive oxygen species-inducing titanium peroxide nanoparticles as promising radiosensitizers for eliminating pancreatic cancer stem cells
    Mohammed Salah et al, 2022, Journal of Experimental & Clinical Cancer Research CrossRef
15. Traditional Chinese medicine may be further explored as candidate drugs for pancreatic cancer: A review
    Yue Gao et al, 2021, Phytotherapy Research CrossRef
16. Breast Cancer Stem Cell Therapeutics, Multiple Strategies Versus Using Engineered Mesenchymal Stem Cells With Notch Inhibitory Properties: Possibilities and Perspectives
    Bipasha Bose et al, 2018, Journal of Cellular Biochemistry CrossRef
17. Bufalin inhibits gastric cancer invasion and metastasis by down-regulating Wnt/ASCL2 expression
    Jie Wang et al, 2018, Oncotarget CrossRef
18. An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives
    Qingmei Ye et al, 2023, Frontiers in Pharmacology CrossRef
19. Bufalin reverses acquired drug resistance by inhibiting stemness in colorectal cancer cells
    Jian Sun et al, 2017, Oncology Reports CrossRef
20. Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism
    J. Wei et al, 2022, Clinical and Translational Oncology CrossRef